Nanobiotix S.a. balance sheet

At the end of fiscal 2025, Nanobiotix S.a. had total assets of $79.5m, total liabilities of $179m and shareholders' equity of −$99.1m. It held $61.9m in cash against $0 of debt: net cash of $61.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Nanobiotix S.a.: balance sheet, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	41	39	146	95	44	83	51	62
Total current assets	49	52	153	105	56	97	64	74
Total assets	59	63	164	115	64	104	70	80
Total current liabilities	14	16	23	42	41	55	61	67
Total debt	—	0	0	0	0	0	0	0
Total liabilities	—	—	—	—	—	106	138	179
Shareholders' equity	16	−2	86	30	−29	−2	−68	−99
Net debt (negative = net cash)	−41	−39	−146	−95	−44	−83	−51	−62

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: FHTX vs NBTX NBTX vs ZYME CUE vs NBTX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Nanobiotix S.a.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Nanobiotix S.a.